Won-Il Choi

1.6k total citations
69 papers, 949 citations indexed

About

Won-Il Choi is a scholar working on Pulmonary and Respiratory Medicine, Epidemiology and Internal Medicine. According to data from OpenAlex, Won-Il Choi has authored 69 papers receiving a total of 949 indexed citations (citations by other indexed papers that have themselves been cited), including 38 papers in Pulmonary and Respiratory Medicine, 20 papers in Epidemiology and 16 papers in Internal Medicine. Recurrent topics in Won-Il Choi's work include Respiratory Support and Mechanisms (20 papers), Venous Thromboembolism Diagnosis and Management (16 papers) and Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (13 papers). Won-Il Choi is often cited by papers focused on Respiratory Support and Mechanisms (20 papers), Venous Thromboembolism Diagnosis and Management (16 papers) and Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (13 papers). Won-Il Choi collaborates with scholars based in South Korea, United States and Ireland. Won-Il Choi's co-authors include Choong Won Lee, Jae Seok Park, Sun Hyo Park, Chae‐Man Lim, Hyun Jung Kim, Younsuck Koh, Sang‐Bum Hong, Heung-Bum Lee, Young Joo Lee and Jong-Joon Ahn and has published in prestigious journals such as SHILAP Revista de lepidopterología, Blood and PLoS ONE.

In The Last Decade

Won-Il Choi

64 papers receiving 926 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Won-Il Choi South Korea 17 372 348 179 126 108 69 949
Tevfik Özlü Türkiye 17 291 0.8× 167 0.5× 297 1.7× 56 0.4× 177 1.6× 77 838
Marianne Schoorl Netherlands 17 243 0.7× 197 0.6× 74 0.4× 52 0.4× 79 0.7× 49 956
Nurdan Köktürk Türkiye 20 723 1.9× 205 0.6× 71 0.4× 92 0.7× 74 0.7× 99 1.1k
Christine Lorut France 12 305 0.8× 197 0.6× 366 2.0× 218 1.7× 201 1.9× 33 904
Stuart McKechnie United Kingdom 14 115 0.3× 192 0.6× 94 0.5× 89 0.7× 73 0.7× 38 800
Mathilde Gisselbrecht France 17 132 0.4× 182 0.5× 103 0.6× 40 0.3× 169 1.6× 41 901
Pei‐Chun Fan Taiwan 22 303 0.8× 252 0.7× 51 0.3× 91 0.7× 241 2.2× 86 1.4k
Nicola Mumoli Italy 20 196 0.5× 217 0.6× 417 2.3× 142 1.1× 394 3.6× 104 1.2k
Carlo Nozzoli Italy 19 198 0.5× 292 0.8× 50 0.3× 252 2.0× 366 3.4× 84 1.1k
Yasuhiro Ohtomo Japan 7 132 0.4× 548 1.6× 180 1.0× 52 0.4× 142 1.3× 8 839

Countries citing papers authored by Won-Il Choi

Since Specialization
Citations

This map shows the geographic impact of Won-Il Choi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Won-Il Choi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Won-Il Choi more than expected).

Fields of papers citing papers by Won-Il Choi

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Won-Il Choi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Won-Il Choi. The network helps show where Won-Il Choi may publish in the future.

Co-authorship network of co-authors of Won-Il Choi

This figure shows the co-authorship network connecting the top 25 collaborators of Won-Il Choi. A scholar is included among the top collaborators of Won-Il Choi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Won-Il Choi. Won-Il Choi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Maher, Toby M., Miguel Bergna, Amy Hajari Case, et al.. (2025). Deupirfenidone Compared to Placebo and Pirfenidone in Idiopathic Pulmonary Fibrosis: ELEVATE IPF Phase 2b Trial. American Journal of Respiratory and Critical Care Medicine. 211(Supplement_1). A7046–A7046. 1 indexed citations
2.
Sim, Jae Kyeom, Sang‐Min Lee, Hyung Koo Kang, et al.. (2024). Association between mechanical power and intensive care unit mortality in Korean patients under pressure-controlled ventilation. Acute and Critical Care. 39(1). 91–99. 3 indexed citations
3.
Rhee, Chin Kook, Seong Yong Lim, Won‐Yeon Lee, et al.. (2024). The effect of nebulized N-acetylcysteine on the phlegm of chronic obstructive pulmonary disease: the NEWEST study. BMC Pulmonary Medicine. 24(1). 434–434.
4.
Choi, Won-Il, et al.. (2023). Properties of Pleural Mesothelial Cells in Idiopathic Pulmonary Fibrosis and Cryptogenic Organizing Pneumonia. Journal of Korean Medical Science. 38(31). e242–e242. 3 indexed citations
5.
Choi, Joon Young, Ki Uk Kim, Deog Kyeom Kim, et al.. (2023). Pulmonary Rehabilitation Is Associated With Decreased Exacerbation and Mortality in Patients With COPD. CHEST Journal. 165(2). 313–322. 7 indexed citations
6.
Lee, Hyeon‐Jeong, Hye Jin Jang, Won-Il Choi, et al.. (2023). Comparison of safety and efficacy between therapeutic or intermediate versus prophylactic anticoagulation for thrombosis in COVID-19 patients: a systematic review and meta-analysis. Acute and Critical Care. 38(2). 160–171. 2 indexed citations
7.
8.
9.
Lee, Hyeon‐Jeong, et al.. (2022). Efficacy and safety of prone position in COVID-19 patients with respiratory failure: a systematic review and meta-analysis. European journal of medical research. 27(1). 310–310. 7 indexed citations
10.
Kim, Taehee, Jung Soo Kim, Eun Young Choi, et al.. (2020). Utilization of pain and sedation therapy on noninvasive mechanical ventilation in Korean intensive care units: a multi-center prospective observational study. Acute and Critical Care. 35(4). 255–262. 8 indexed citations
11.
Choi, Won-Il, et al.. (2019). Association between EGFR mutation and ageing, history of pneumonia and gastroesophageal reflux disease among patients with advanced lung cancer. European Journal of Cancer. 122. 101–108. 13 indexed citations
12.
Hong, Junshik, Ju Hyun Lee, Ji Yun Lee, et al.. (2019). Prominent seasonal variation in pulmonary embolism than deep vein thrombosis incidence: a Korean venous thrombosis epidemiology study. The Korean Journal of Internal Medicine. 35(3). 682–691. 7 indexed citations
13.
Choi, Won-Il, et al.. (2018). Risk factors for interstitial lung disease: a 9-year Nationwide population-based study. BMC Pulmonary Medicine. 18(1). 96–96. 57 indexed citations
14.
Choi, Won-Il, et al.. (2018). Higher Age Puts Lung Cancer Patients at Risk for Not Receiving Anti-cancer Treatment. Cancer Research and Treatment. 51(3). 1241–1248. 8 indexed citations
15.
Na, Soo Jin, Tae Sun Ha, Gee Young Suh, et al.. (2018). Characteristics and Clinical Outcomes of Critically Ill Cancer Patients Admitted to Korean Intensive Care Units. Acute and Critical Care. 33(3). 121–129. 13 indexed citations
16.
Kwon, Yong Shik, Sun Hyo Park, Mi Ae Kim, et al.. (2017). Risk of mortality associated with respiratory syncytial virus and influenza infection in adults. BMC Infectious Diseases. 17(1). 785–785. 67 indexed citations
17.
Lee, Mi‐Young, et al.. (2015). Clinical findings and outcomes in patients with possible usual interstitial pneumonia. Respiratory Medicine. 109(4). 510–516. 26 indexed citations
18.
Choi, Won-Il, So Yeon Lim, Shin Ok Koh, et al.. (2014). Markers of poor outcome in patients with acute hypoxemic respiratory failure. European Respiratory Journal. 44(Suppl 58). P2066–P2066. 5 indexed citations
19.
Hong, Sang‐Bum, Won-Il Choi, Jong-Joon Ahn, et al.. (2011). Corticosteroid Treatment in Critically Ill Patients with Pandemic Influenza A/H1N1 2009 Infection: Analytic Strategy Using Propensity Scores. American Journal of Respiratory and Critical Care Medicine. 183(9). 1207–1214. 169 indexed citations
20.
Lee, Sang‐Won, et al.. (2004). Validity of peak expiratory flow for assessing the presence of airflow obstruction. The Korean Journal of Internal Medicine. 67(2). 170–175. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Tevfik Özlü Breakdown of academic impact, for papers by Marianne Schoorl Breakdown of academic impact, for papers by Nurdan Köktürk Breakdown of academic impact, for papers by Christine Lorut Breakdown of academic impact, for papers by Stuart McKechnie Breakdown of academic impact, for papers by Mathilde Gisselbrecht Breakdown of academic impact, for papers by Pei‐Chun Fan Breakdown of academic impact, for papers by Nicola Mumoli Breakdown of academic impact, for papers by Carlo Nozzoli Breakdown of academic impact, for papers by Yasuhiro Ohtomo
Rankless by CCL
2026